The In Vivo Imaging Workspace, part of the National Cancer Institute’s biomedical informatics grid, is now a fully functional operation that is actively seeking participation from cancer centers, industry, organizations, and standards groups.
The In Vivo Imaging Workspace, part of the National Cancer Institute's biomedical informatics grid, is now a fully functional operation that is actively seeking participation from cancer centers, industry, organizations, and standards groups.
The workspace's first face-to-face meeting is set for Dec. 15 and 16 in Philadelphia. The goal is to quickly identify short-term, low-cost, and low-risk projects for the group's first year, according to Dr. Eliot Siegel, vice chair of information systems at the University of Maryland and chief of radiology and nuclear medicine at the Maryland Health Care System.
Participation is not limited to large organizations and vendors, and individual as well as international participation is encouraged.
"We want to involve a wide range of participants," he said.
The cancer biomedical informatics grid, or caBIG, was launched in February 2004. It brings together investigators and research teams who can combine and leverage their findings and expertise to meet the NCI's goal of eliminating suffering and death due to cancer by 2015, said Siegel, the workspace's lead.
caBIG has four domain virtual "workspaces": clinical trials management systems, integrative cancer research, tissue banks and pathology tools, and in vivo imaging.
Imaging plays a large part in achieving NCI's stated goal - hence the development of the in vivo imaging workspace, the newest addition to caBIG just launched in October.
During a an RSNA 2005 meeting scientific session, Siegel outlined his own priorities for the imaging workspaces to develop:
More information can be found at caBIG.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.